Zim Laboratories is currently trading at Rs. 110.95, up by 1.15 points or 1.05% from its previous closing of Rs. 109.80 on the BSE.
The scrip opened at Rs. 111.10 and has touched a high and low of Rs. 111.80 and Rs. 109.95 respectively. So far 4659 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 131.30 on 24-Apr-2024 and a 52 week low of Rs. 89.90 on 13-Mar-2024.
Last one week high and low of the scrip stood at Rs. 112.75 and Rs. 105.00 respectively. The current market cap of the company is Rs. 541.83 crore.
The promoters holding in the company stood at 33.26%, while Non-Institutions held 66.73% stake in the company.
ZIM Laboratories has received approval from Board of Directors to invest upto Euro 1,50,000 in the equity shares of SIA ZIM Laboratories, wholly owned subsidiary of the company. The investment in equity shares of SIA ZIM Laboratories is with an objective of expansion and development of business in the European region.
With the proposed investment, the Company’s shareholding in SIA ZIM Laboratories remains at 100%. The Board of Directors in their meeting held on September 30, 2024 have considered and inter alia approved the same.
ZIM Laboratories manufactures, formulates, and distributes drug delivery systems to develop generic pharmaceutical products.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1693.15 |
| Dr. Reddys Lab | 1221.25 |
| Cipla | 1230.75 |
| Zydus Lifesciences | 939.20 |
| Lupin | 2326.50 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: